Software developer Confirma has granted Hologic nonexclusive distribution rights to its CADstream system for processing data-intensive breast MRI studies. Confirma is also integrating CADstream with Hologic's full-field digital Lorad Selenia system to
Software developer Confirma has granted Hologic nonexclusive distribution rights to its CADstream system for processing data-intensive breast MRI studies. Confirma is also integrating CADstream with Hologic's full-field digital Lorad Selenia system to provide simultaneous viewing of mammography and breast MR studies.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Key MRI Findings Predictive of Treatment Response for Unresectable Hepatocellular Carcinoma
July 14th 2025For patients with unresectable hepatocellular carcinoma, a pre-treatment MRI finding of LI-RADS tumor in vein was associated with over an 86 percent lower likelihood of responding to transcatheter arterial chemoembolization (TACE) and targeted immunotherapy.